Biosimilars in clinical trials & key regulatory considerations
The growth in the biosimilar market since 2006 has been significant. Biosimilars have no meaningful clinical differences between the...
Biosimilars in clinical trials & key regulatory considerations
Mission Impossible Case Study
Innovation delivered: oncology drug development
Saving hundreds of thousands of euros to a biotech company
12 Case Studies of Christmas
Blockbuster oncology products in clinical trials supplies
Identifying risks in clinical trial supplies & comparator sourcing